Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025 - Report - MDSpire

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

  • By

  • April 25, 2025

  • 11 min

Share

Clinical Report: Roswell Park Researchers to Discuss Oncology Discoveries at AACR 2025

Overview

Researchers from Roswell Park Comprehensive Cancer Center will present significant findings at the AACR 2025 annual meeting, focusing on partnerships with Indigenous nations and advancements in cancer therapies. Key presentations will include results from clinical trials on non-small cell lung cancer and breast cancer.

Background

The AACR annual meeting is a pivotal event for oncology professionals to share groundbreaking research and clinical advancements. The integration of Indigenous perspectives in cancer research is crucial for addressing health disparities and improving outcomes in these communities. Furthermore, ongoing clinical trials are essential for developing innovative therapies that enhance patient care.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Dr. Rodney Haring will discuss a model for partnerships between cancer centers and Indigenous nations.
  • Initial results from a phase 1 study of an A2a receptor antagonist in advanced non-small cell lung cancer will be presented by Dr. Prantesh Jain.
  • Dr. Gokul Das will present findings on a novel therapeutic strategy against triple negative breast cancer.
  • Research on CAR T cell responses in multiple myeloma will be discussed by Dr. Scott Olejniczak.
  • Investigations into sex disparities in bladder cancer will be presented by Bhavisha Doshi.

Clinical Implications

The findings presented at AACR 2025 highlight the importance of collaborative approaches in cancer research, particularly with Indigenous communities. Clinicians should consider these partnerships as a model for addressing health disparities and improving cancer care delivery.

Conclusion

The AACR 2025 meeting will showcase critical advancements in oncology, emphasizing the need for innovative research and community engagement in cancer care.

References

  1. Roswell Park Comprehensive Cancer Center, Join Roswell Park at AACR 2026, 2025 -- Join Roswell Park at AACR 2026
  2. Roswell Park Comprehensive Cancer Center, ASCO 2025 Highlights, 2025 -- ASCO 2025 Highlights: Menin Inhibitor for Acute Myeloid Leukemia; Organ Transplant and Checkpoint Inhibitors
  3. Roswell Park Comprehensive Cancer Center, Roswell Park Quick Talks, 2025 -- Roswell Park Quick Talks: Breast Cancer and ADCs, Risk of Second HPV-Related Cancer, Cognitive Function and ICIs
  4. roswell park comprehensive cancer center — Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference
  5. Adding Perioperative Nivolumab to Neoadjuvant Chemotherapy in Resectable NSCLC CheckMate 77T - The ASCO Post
  6. Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer - PMC
  7. NCCN Updates ctDNA Stance in Colon, Rectal, and MCC Guidelines | OncLive

Original Source(s)

Related Content